- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06004063
조혈모세포이식 환자에서 경장영양과 대외영양의 안전성, 내약성 및 효능: 파일럿 무작위 통제 연구
The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
연구 개요
상세 설명
Primary Objective:
a. To determine the feasibility, acceptability, and safety of NG tube feeding compared with patients not electing NG tube feeding.
Secondary Objectives:
- Determine the differential effects of enteral feeding versus Parenteral feeding on nutrition, and quality of life.
- Determine the differential effects of enteral feeding versus parenteral feeding on survival and, medical comorbidities
- Determine the differential effects of enteral feeding versus parenteral feeding on Fitbit data study for patients co-enrolled in Pediatric Energy Balance Data Repository Protocol PA18-0130.
- Identify differential effects on microbiome for patients co-enrolled on MDACC protocol 2014-0938 "Longitudinal Biospecimen Acquisition for All Tumor Types And At-Risk Tissue
- Determine adverse effects of enteral feeding in this population
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Shehla Razvi, MD
- 전화번호: (713) 792-6635
- 이메일: srazvi@mdanderson.org
연구 연락처 백업
- 이름: Karen Moody, MD
- 전화번호: 713-792-6610
- 이메일: kmoody@mdanderson.org
연구 장소
-
-
Texas
-
Houston, Texas, 미국, 77030
- 모병
- M D Anderson Cancer Center
-
연락하다:
- Shehla Razvi, MD
- 전화번호: 713-792-6635
- 이메일: srazvi@mdanderson.org
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Have plans to be admitted or be admitted to an inpatient pediatric or adult ward for the purpose of HSCT.
-
Be greater than 2 years of age and less than 25 years of age at time of study enrollment.
-
Participants > 18 or guardians for participants < 18 are willing and able to give written informed consent and to comply with all of the study activities. Assent is required for children > 7 years old.
a) Participants must be English, Italian, Chinese/Mandarin, or Spanish speaking
-
Participants will be encouraged to co-enroll on two additional related energy -balance protocols (highly encouraged but not required)
- MDACC protocol PA18-0130. This protocol will enable us to track physical activity through their receipt of a Fitbit (Pediatric Energy Balance Data Repository Protocol.) , and
- MDACC protocol LAB99-062 "A Study to Collect Peripheral Blood, Tissue, and Bone Marrow samples from Donors and Recipients of blood and marrow transplants for Laboratory Research" which will allow collection of stool for exploration of the effects of feeding on microbiome data specifically.
-
Participants will be asked to consider co-enrollment on Stem Cell Registry study (not required):
- PA19-0756: This is a prospective multi-center study to understand the contribution of vascular endothelial dysfunction towards morbidity and mortality among children and adolescents/young adults (AYA) undergoing HCT/CT.
Exclusion Criteria:
- Patients in whom EN is contraindicated (e.g intestinal ischemia, complete bowel obstruction, or other anatomical obstructive process), or all available routes of EN are contraindicated. Surgical GT placements for the sole purpose of study participation will not be entertained. See Table 1
- Females who are pregnant. We follow FACT guidelines. Per Foundation for the Accreditation of Cellular Therapy (FACT), female patients must have a negative pregnancy test 7 days prior to bone marrow transplant.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Enteral nutrition (EN)-Group 1
Participants will receive enteral feeding (directly into the stomach) based on your ability to receive your daily caloric needs by mouth. Participants will be monitored by a dietician and may receive feeding by vein to achieve caloric goals. |
Given by Nasogastric Tube Given by PO or Given by IV (vein) |
|
활성 비교기: Standard care parenteral nutrition (PN)-Group 2
Participants will receive the standard of care. Participants will be monitored by a dietician to see if the participants are able to receive your daily caloric needs by mouth. Some participants may be able to receive oral dietary supplements, but if this is not possible or not enough, participants will begin receiving standard of care feeding by vein. |
Given by PO or Given by IV (vein) |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
부작용의 발생률, 국립 암 연구소 부작용에 대한 공통 용어 기준(NCI CTCAE) 버전(v) 5.0에 따라 등급이 매겨짐
기간: 연구 완료를 통해; 평균 1년.
|
연구 완료를 통해; 평균 1년.
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Shehla Razvi, MD, M.D. Anderson Cancer Center
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .